Clinical Trial Update: In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of an in vivo CAR-T therapy for relapsed/refractory hematologic cancers is currently recruiting. The study targets B-cell acute lymphob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• B-cell Non-hodgkin Lymphoma
• Multiple Myeloma

Drugs mentioned

• In Vivo CAR-T Therapy

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: B-Acute Lymphoblastic Leukemia, B Cell Non-Hodgkin's Lymphoma | Phase 1 | Status: RECRUITING